Tagged with Pharmax

The UAE: A Gathering Force

Long Read The UAE: A Gathering Force

Long Read Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most of whom seemed more intent on chasing demand in the decidedly more populous Asian market space. But, with an estimated annual growth rate of 10 percent,…

Madhukar Tanna – CEO, Pharmax, UAE

UAE Madhukar Tanna – CEO, Pharmax, UAE

UAE Pharmax, a Dubai-based manufacturer and distributor of generic medications, is aiming to shake up the UAE’s healthcare system with its affordable and high-quality medications. CEO Madhukar Tanna highlights the recent EU GMP approval of its manufacturing plant and explains the overall impact that generic medications can have in reducing costs…

The Power of Taiwanese Technology

Taiwan The Power of Taiwanese Technology

Taiwan Leveraging Taiwan’s remarkable talent pool in chemistry, some of the country’s fastest-growing companies have been concentrating their efforts on technology platforms that allow them to develop a plethora of potentially game-changing products, rather than focusing all their resources on the risky development of a single, potentially groundbreaking product. Taiwan…

Interview: CS Hsu Ph.D. – President, Innopharmax, Taiwan

Taiwan Interview: CS Hsu Ph.D. – President, Innopharmax, Taiwan

Taiwan Ten years after its creation in 2005, InnoPharmax was ranked seventh fastest growing technology company in Taiwan in Deloitte’s “Technology Fast 500 Asia Pacific” annual ranking. CS Hsu, founder and president of InnoPharmax, introduces the company’s most fundamental asset – OralPAS®, its unique technology platform, and documents the promising development…

Ahmad Tabari – Managing Director, Pharmax, UAE

UAE Ahmad Tabari – Managing Director, Pharmax, UAE

UAE Ahmad Tabari, Managing Director of Pharmax, gives his insight into the regions major challenges, why he thinks that, regardless of the amount of money the government invests, the problem of a small talent pool in the industry will not go away quickly or easily, and Pharmax’s strategy to overcome this…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page